These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8386506)
1. The thyroid hormone receptor interferes with transcriptional activation via the AP-1 complex. Schmidt ED; Cramer SJ; Offringa R Biochem Biophys Res Commun; 1993 Apr; 192(1):151-60. PubMed ID: 8386506 [TBL] [Abstract][Full Text] [Related]
2. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun. Sharif M; Privalsky ML Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165 [TBL] [Abstract][Full Text] [Related]
3. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter. Rascle A; Ghysdael J; Samarut J Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146 [TBL] [Abstract][Full Text] [Related]
4. An activator protein-1 (AP-1) response element on pro alpha1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts. Lee HW; Klein LE; Raser J; Eghbali-Webb M J Mol Cell Cardiol; 1998 Nov; 30(11):2495-506. PubMed ID: 9925384 [TBL] [Abstract][Full Text] [Related]
5. A c-erb-A binding site in rat growth hormone gene mediates trans-activation by thyroid hormone. Glass CK; Franco R; Weinberger C; Albert VR; Evans RM; Rosenfeld MG Nature; 1987 Oct 22-28; 329(6141):738-41. PubMed ID: 3313046 [TBL] [Abstract][Full Text] [Related]
6. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Koenig RJ; Lazar MA; Hodin RA; Brent GA; Larsen PR; Chin WW; Moore DD Nature; 1989 Feb; 337(6208):659-61. PubMed ID: 2537467 [TBL] [Abstract][Full Text] [Related]
8. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Agadir A; Shealy YF; Hill DL; Zhang X Cancer Res; 1997 Aug; 57(16):3444-50. PubMed ID: 9270011 [TBL] [Abstract][Full Text] [Related]
9. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression. Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013 [TBL] [Abstract][Full Text] [Related]
10. Negative transcriptional regulation by nuclear receptors. Saatcioglu F; Claret FX; Karin M Semin Cancer Biol; 1994 Oct; 5(5):347-59. PubMed ID: 7849263 [TBL] [Abstract][Full Text] [Related]
11. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency. Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652 [TBL] [Abstract][Full Text] [Related]
12. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor. Kim S; Brown PH; Birrer MJ Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795 [TBL] [Abstract][Full Text] [Related]
13. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor. Bhat MK; McPhie P; Cheng S Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018 [TBL] [Abstract][Full Text] [Related]
14. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner. Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543 [TBL] [Abstract][Full Text] [Related]
15. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site. Andersson ML; Vennström B Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561 [TBL] [Abstract][Full Text] [Related]
16. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Claret FX; Hibi M; Dhut S; Toda T; Karin M Nature; 1996 Oct; 383(6599):453-7. PubMed ID: 8837781 [TBL] [Abstract][Full Text] [Related]
17. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Kim H; Lee JE; Cho EJ; Liu JO; Youn HD Cancer Res; 2003 Oct; 63(19):6135-9. PubMed ID: 14559791 [TBL] [Abstract][Full Text] [Related]
18. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites. Wahlström GM; Harbers M; Vennström B Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Niederman TM; Hastings WR; Luria S; Bandres JC; Ratner L Virology; 1993 May; 194(1):338-44. PubMed ID: 8480425 [TBL] [Abstract][Full Text] [Related]
20. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Sap J; Muñoz A; Damm K; Goldberg Y; Ghysdael J; Leutz A; Beug H; Vennström B Nature; 1986 Dec 18-31; 324(6098):635-40. PubMed ID: 2879242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]